Correlation Between Tarsus Pharmaceuticals and COMCAST

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and COMCAST at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and COMCAST into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and COMCAST PORATION, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and COMCAST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of COMCAST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and COMCAST.

Diversification Opportunities for Tarsus Pharmaceuticals and COMCAST

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tarsus and COMCAST is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and COMCAST PORATION in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMCAST PORATION and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with COMCAST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMCAST PORATION has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and COMCAST go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and COMCAST

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 5.7 times less return on investment than COMCAST. But when comparing it to its historical volatility, Tarsus Pharmaceuticals is 11.66 times less risky than COMCAST. It trades about 0.08 of its potential returns per unit of risk. COMCAST PORATION is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  8,329  in COMCAST PORATION on September 14, 2024 and sell it today you would earn a total of  706.00  from holding COMCAST PORATION or generate 8.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy96.57%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  COMCAST PORATION

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
COMCAST PORATION 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in COMCAST PORATION are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, COMCAST is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Tarsus Pharmaceuticals and COMCAST Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and COMCAST

The main advantage of trading using opposite Tarsus Pharmaceuticals and COMCAST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, COMCAST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMCAST will offset losses from the drop in COMCAST's long position.
The idea behind Tarsus Pharmaceuticals and COMCAST PORATION pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios